Navigation Links
UTSA wins $500,000 to develop biosensor and regenerative medicine Ph.D. program
Date:2/18/2009

San Antonio The University of Texas at San Antonio (UTSA) announced today it will receive $500,000 from The University of Texas System over the next five years to develop a unique Graduate Program Initiative emphasizing biosensors and regenerative medicine. Of the 37 proposals received by the UT System from its nine academic and six health institutions, only seven were funded and only two were awarded to academic institutions. UTSA's Graduate Program Initiative builds upon existing programs in its College of Engineering and College of Sciences to prepare students for careers in academia, federal agencies and the biomedical industry.

"This program will provide qualified students with an exciting opportunity to pursue interdisciplinary research in science and engineering. This unique program will allow students to integrate courses and research training in biomedical engineering, electrical engineering and/or chemistry into their educational curriculum," said Dorothy Flannagan, dean of UTSA's Graduate School.

"Funding from this grant will foster and formalize new innovative collaborations among participating faculty and students," added Anson Ong, USAA Foundation Distinguished Professor and chair of UTSA's Department of Biomedical Engineering. "Each academic discipline has a different way of thinking and a different way of solving problems. By working together, the students in this program initiative will better understand the complex healthcare problems as well as finding novel and innovative solutions to solving these problems."

Regenerative medicine and biosensors are key elements for the advancement of science and the improvement of human health. Regenerative medicine allows scientists and practitioners to regenerate functional tissues in patients. Current treatments use tissues from the patient's own body or from a cadaver. However, both approaches have many potential risks. A biosensor is a device that allows scientists to detect biological chemicals such as enzymes, antibodies and disease-representing biomarkers, thereby providing early diagnosis and detection and improving treatments.

To learn more about UTSA's new interdisciplinary Ph.D. program, contact Anson Ong at anson.ong@utsa.edu or (210) 458-7149. To learn more about UTSA's graduate programs, visit http://utsa.edu/graduate/.


'/>"/>

Contact: Christi Fish
christi.fish@utsa.edu
210-458-7584
University of Texas at San Antonio
Source:Eurekalert

Related biology news :

1. Shigetada Nakanishi receives $500,000 Gruber Neuroscience Prize
2. Maynard Olson receives $500,000 Gruber Genetics Prize
3. Veterinarians developing model to help producers, vets make cattle more comfortable
4. When acute hepatitis develops into chronic hepatitis
5. Iowa student engineers develop hand-held water sanitizer for a thirsty world
6. Preventing rangeland erosion: Developing better management practices in Iran
7. Singapore-US scientists first to develop revolutionary microchip that uses 30 times less energy
8. Carnegies Donald Brown receives lifetime achievement award from Society for Developmental Biology
9. New vaccine developed for preventing uncommon cold virus
10. Fujitsu Develops HDD Security Technology Based on Opal SSC Standards
11. UT to develop fracture putty for traumatic leg injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: